AAOMS Annual Meeting

Conference Coverage

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

Seizure
Seizure
FDA Approves Generic Drug for Epilepsy
01/11/2019
The medication is to be used as an adjunctive therapy in adult and pediatric patients with complex partial seizures.
01/11/2019
Seizure
Seizure
FDA Approves Generic Drug for Epilepsy
01/11/2019
The medication is to be used as an adjunctive therapy in adult and pediatric patients with complex partial seizures.
01/11/2019
Seizure
Seizure
FDA Approves Generic Drug for Epilepsy
01/11/2019
The medication is to be used as an adjunctive therapy in adult and pediatric patients with complex partial seizures.
01/11/2019
FDA
FDA
FDA Approves Hexavalent Combination Vaccine for Children
12/27/2018
The US Food and Drug Administration has granted approval to a new vaccine for young children that protects against 6 diseases.
12/27/2018
FDA
FDA
FDA Approves Hexavalent Combination Vaccine for Children
12/27/2018
The US Food and Drug Administration has granted approval to a new vaccine for young children that protects against 6 diseases.
12/27/2018
FDA
FDA
FDA Approves Hexavalent Combination Vaccine for Children
12/27/2018
The US Food and Drug Administration has granted approval to a new vaccine for young children that protects against 6 diseases.
12/27/2018
FDA
FDA
FDA Approves New Drug for Chronic Idiopathic Constipation
12/20/2018
The FDA has approved a selective serotonin-4 (5-HT4) receptor agonist to treat adults with chronic idiopathic constipation, a condition that affects 14% of the adult population.
12/20/2018
Multiple Sclerosis
Multiple Sclerosis
FDA: Stopping MS Medication May Exacerbate Symptoms
11/26/2018
The FDA has released a warning about the potential for an increase in disability in patients with multiple sclerosis who stop taking this immunosuppressant.
11/26/2018
Multiple Sclerosis
Multiple Sclerosis
FDA: Stopping MS Medication May Exacerbate Symptoms
11/26/2018
The FDA has released a warning about the potential for an increase in disability in patients with multiple sclerosis who stop taking this immunosuppressant.
11/26/2018
Multiple Sclerosis
Multiple Sclerosis
FDA: Stopping MS Medication May Exacerbate Symptoms
11/26/2018
The FDA has released a warning about the potential for an increase in disability in patients with multiple sclerosis who stop taking this immunosuppressant.
11/26/2018